Kim De Keersmaecker

6.1k total citations
67 papers, 3.1k citations indexed

About

Kim De Keersmaecker is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kim De Keersmaecker has authored 67 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 30 papers in Hematology and 29 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kim De Keersmaecker's work include Acute Lymphoblastic Leukemia research (29 papers), Chronic Myeloid Leukemia Treatments (22 papers) and RNA modifications and cancer (21 papers). Kim De Keersmaecker is often cited by papers focused on Acute Lymphoblastic Leukemia research (29 papers), Chronic Myeloid Leukemia Treatments (22 papers) and RNA modifications and cancer (21 papers). Kim De Keersmaecker collaborates with scholars based in Belgium, United States and Netherlands. Kim De Keersmaecker's co-authors include Jan Cools, Kim R. Kampen, Sergey O. Sulima, Adolfo A. Ferrando, Tiziana Girardi, Carmen Vicente, Peter Marynen, Peter Vandenberghe, Stijn Vereecke and Nicole Mentens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Kim De Keersmaecker

64 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim De Keersmaecker Belgium 32 1.9k 861 859 601 491 67 3.1k
Josée Hébert Canada 33 2.2k 1.1× 251 0.3× 947 1.1× 389 0.6× 550 1.1× 93 3.1k
Markus Müschen United States 40 2.0k 1.0× 722 0.8× 984 1.1× 493 0.8× 1.1k 2.2× 165 4.3k
Jeffery M. Klco United States 28 2.0k 1.1× 263 0.3× 1.2k 1.4× 842 1.4× 495 1.0× 85 3.2k
Tim C. P. Somervaille United Kingdom 29 3.3k 1.7× 195 0.2× 1.7k 2.0× 435 0.7× 654 1.3× 105 4.4k
Thomas Kindler Germany 27 1.5k 0.8× 253 0.3× 1.7k 1.9× 257 0.4× 615 1.3× 78 3.0k
Nianxiang Zhang United States 25 1.6k 0.8× 137 0.2× 457 0.5× 328 0.5× 315 0.6× 47 2.1k
Hironori Harada Japan 25 1.9k 1.0× 214 0.2× 1.9k 2.2× 416 0.7× 357 0.7× 110 3.1k
David Flowers United States 20 1.7k 0.9× 243 0.3× 988 1.2× 105 0.2× 933 1.9× 43 3.2k
Anupama Narla United States 22 3.0k 1.6× 103 0.1× 1.1k 1.3× 266 0.4× 738 1.5× 53 3.9k
Kalindi Parmar United States 28 2.1k 1.1× 93 0.1× 706 0.8× 586 1.0× 862 1.8× 60 3.0k

Countries citing papers authored by Kim De Keersmaecker

Since Specialization
Citations

This map shows the geographic impact of Kim De Keersmaecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim De Keersmaecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim De Keersmaecker more than expected).

Fields of papers citing papers by Kim De Keersmaecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim De Keersmaecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim De Keersmaecker. The network helps show where Kim De Keersmaecker may publish in the future.

Co-authorship network of co-authors of Kim De Keersmaecker

This figure shows the co-authorship network connecting the top 25 collaborators of Kim De Keersmaecker. A scholar is included among the top collaborators of Kim De Keersmaecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim De Keersmaecker. Kim De Keersmaecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keersmaecker, Kim De, et al.. (2025). Ribosome specialization by cancer-associated ribosomal protein mutations: progress made and open questions. Philosophical Transactions of the Royal Society B Biological Sciences. 380(1921). 20230380–20230380. 1 indexed citations
2.
Gielen, Olga, Jochen Lamote, Barbara Dewaele, et al.. (2025). Single‐cell DNA and surface protein characterization of high hyperdiploid acute lymphoblastic leukemia at diagnosis and during treatment. HemaSphere. 9(2). e70085–e70085.
3.
Sonveaux, Pierre, Kim De Keersmaecker, Barbara Dewaele, et al.. (2024). Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas. Oncogenesis. 13(1). 39–39. 4 indexed citations
4.
Lieuwes, Natasja G., Rianne Biemans, Ludwig J. Dubois, et al.. (2023). Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer. British Journal of Cancer. 130(4). 568–584. 11 indexed citations
5.
Zaunz, Samantha, Jonathan De Smedt, Charlie Laffeber, et al.. (2023). APEX1 Nuclease and Redox Functions are Both Essential for Adult Mouse Hematopoietic Stem and Progenitor Cells. Stem Cell Reviews and Reports. 19(6). 2052–2072. 2 indexed citations
6.
Venken, Tom, David Nittner, Jelle Verbeeck, et al.. (2023). Transcription factor NKX2–1 drives serine and glycine synthesis addiction in cancer. British Journal of Cancer. 128(10). 1862–1878. 14 indexed citations
7.
Kampen, Kim R., Gianmarco Rinaldi, Mélanie Planque, et al.. (2020). Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth. Molecular Cancer Therapeutics. 20(1). 50–63. 57 indexed citations
8.
Verbeke, Delphine, Sofie Demeyer, Cristina Prieto, et al.. (2020). The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia. Clinical Cancer Research. 26(21). 5747–5758. 21 indexed citations
9.
Davenne, Tamara, Jenny Klintman, Sushma Sharma, et al.. (2020). SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTP. Cell Reports. 31(6). 107640–107640. 10 indexed citations
10.
Servera, Llucia Albertí, Sofie Demeyer, Toon Swings, et al.. (2020). Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia. Blood. 137(6). 801–811. 47 indexed citations
11.
Kampen, Kim R., Frank J.G. Scherpen, Hasan Mahmud, et al.. (2018). VEGFC Antibody Therapy Drives Differentiation of AML. Cancer Research. 78(20). 5940–5948. 11 indexed citations
12.
Sulima, Sergey O., Kim R. Kampen, Stijn Vereecke, et al.. (2018). Ribosomal Lesions Promote Oncogenic Mutagenesis. Cancer Research. 79(2). 320–327. 26 indexed citations
13.
Bie, Jolien De, Sofie Demeyer, Llucia Albertí Servera, et al.. (2018). Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia. Leukemia. 32(6). 1358–1369. 63 indexed citations
14.
Ambesi‐Impiombato, Alberto, Yue Qin, Daniel Herranz, et al.. (2017). Synergistic antileukemic therapies in NOTCH1-induced T-ALL. Clinical Cancer Research. 23(24). 65–66. 1 indexed citations
15.
Porcu, Michaël, Maria Kleppe, Valentina Gianfelici, et al.. (2012). Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia. Blood. 119(19). 4476–4479. 84 indexed citations
16.
Keersmaecker, Kim De. (2011). The other Achilles' heel of BCR-ABL1. Haematologica. 97(1). 2–2. 2 indexed citations
17.
Mavrakis, Konstantinos J., Andrew L. Wolfe, Elisa Oricchio, et al.. (2010). Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nature Cell Biology. 12(4). 372–379. 275 indexed citations
18.
Keersmaecker, Kim De, Idoya Lahortiga, Nicole Mentens, et al.. (2008). In vitro validation of  -secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica. 93(4). 533–542. 58 indexed citations
19.
Keersmaecker, Kim De, Rafael Bernad, Cedric Folens, et al.. (2007). Functional characterization of the T-ALL associated EML1-ABL1 and NUP214-ABL1 oncogenes. Acta Clinica Belgica. 62(4). 260–260. 1 indexed citations
20.
Keersmaecker, Kim De, Willy Landuyt, Peter Vandenberghe, et al.. (2007). EML1-ABL1 is activated by coiled coil mediated oligomerization and induces T-cell acute lymphoblastic or chronic myeloid leukemia in a mouse bone marrow transplant model. 92. 326–326.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josée Hébert Breakdown of academic impact, for papers by Markus Müschen Breakdown of academic impact, for papers by Jeffery M. Klco Breakdown of academic impact, for papers by Tim C. P. Somervaille Breakdown of academic impact, for papers by Thomas Kindler Breakdown of academic impact, for papers by Nianxiang Zhang Breakdown of academic impact, for papers by Hironori Harada Breakdown of academic impact, for papers by David Flowers Breakdown of academic impact, for papers by Anupama Narla Breakdown of academic impact, for papers by Kalindi Parmar
Rankless by CCL
2026